您的位置: 首页 > 农业专利 > 详情页

Antineoplastic Combinations with mTOR Inhibitor, Trastuzumab and/or HKI-272
专利权人:
Charles Zacharchuk;Sridhar K. Rabindran;Laurence Moore
发明人:
Laurence Moore,Charles Zacharchuk,Sridhar K. Rabindran
申请号:
US13454768
公开号:
US20120308560A1
申请日:
2012.04.24
申请国别(地区):
US
年份:
2012
代理人:
摘要:
A combination of temsirolimus and trastuzumab in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of a trastuzumab and a HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing trastuzumab, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充